Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology (ACNP). This journal focuses upon clinical and basic science contributions that advance our understanding of the brain and behavior, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs. While original reports are preferred, mini-reviews and perspectives are invited by the editorial office.

With a 2019 impact factor of 6.751, Neuropsychopharmacology (NPP) ranks 13 of 155 Psychiatry journals, 14 of 270 Pharmacology and Pharmacy journals, and 23 of 271 Neuroscience journals. The journal has a 2019 CiteScore of 12.3  In 2019, on average, articles received a first decision from NPP within 30 days (with review); manuscripts publish online in two weeks from the time they are received by production.

In 2019, NPP saw more than 1.8 million article downloads, and roughly 74,000 visits to its homepage. The journal’s bimonthly podcasts, or BrainPods, generate roughly 370 weekly listens on topics that showcase advancements in our understanding of the brain and behavior. Check us out at www.nature.com/npp!

In view of the interdisciplinary nature of the field, particular emphasis is placed on:

  • studies that advance the biological bases of normal and pathological behavior
  • the nature, etiology and pathophysiology of neuropsychiatric disorders
  • biologically relevant aspects of the epidemiology, diagnosis, and treatment of these disorders
  • the basic mechanisms by which psychopharmacological agents exert their effect

Dr. William A Carlezon Jr, Ph.D.
Editor-in-Chief

About the Editors

Dr. Keri Martinowich, Ph.D.
NPP Social Media Editor

    

Are you receiving Neuropsychopharmacology e-alerts?

Sign up with your e-mail address to receive monthly table of contents alerts and keep informed with Neuropsychopharmacology news and announcements.  Each e-alert features the latest journal commentaries, circumspectives, original research and review articles.